Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 2
Submit an article Journal homepage
869
Views
128
CrossRef citations to date
0
Altmetric
Original

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients

Claudia Schöllkopf Department of Hematology, Herlev University Hospital, Herlev, Denmark
,
Lars Kjeldsen Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
,
Ole Weiss Bjerrum Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
,
Hans Torben Mourits-Andersen Department of Internal Medicine, Esbjerg Hospital, Esbjerg, Denmark
,
Johan Lanng Nielsen Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
,
Bjarne Egelund Christensen Department of Hematology, Odense University Hospital, Odense, Denmark
,
Bjarne Anker Jensen Department of Internal Medicine, Hilleroed Hospital, Hilleroed, Denmark
,
Bjarne Bach Pedersen Department of Internal Medicine, Viborg Hospital, Viborg, Denmark
,
Ellen Birkerod Taaning Department of Clinical Immunology and Blood Bank, Herlev University Hospital, Herlev, Denmark
,
Tobias Wirenfeldt Klausen Department of Hematology, Herlev University Hospital, Herlev, Denmark
&
Henrik Birgens Department of Hematology, Herlev University Hospital, Herlev, DenmarkCorrespondence[email protected]
 show all
Pages 253-260 | Received 28 Jun 2005, Published online: 01 Jul 2009

Citations (128)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Francesca Cavallaro, Wilma Barcellini & Bruno Fattizzo. (2023) Antibody based therapeutics for autoimmune hemolytic anemia. Expert Opinion on Biological Therapy 0:0, pages 1-11.
Read now
Catherine M. Broome. (2023) Complement-directed therapy for cold agglutinin disease: sutimlimab. Expert Review of Hematology 16:7, pages 479-494.
Read now
Georg Gelbenegger, Sigbjørn Berentsen & Bernd Jilma. (2023) Monoclonal antibodies for treatment of cold agglutinin disease. Expert Opinion on Biological Therapy 23:5, pages 395-406.
Read now
Emese K. Vágó, Gina Nicholson, Erzsébet Horváth-Puhó, Naushin Hooda, Jon P. Fryzek & Jun Su. (2021) Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Current Medical Research and Opinion 37:10, pages 1829-1835.
Read now
Sigbjørn Berentsen, Alexander Röth, Ulla Randen, Bernd Jilma & Geir E Tjønnfjord. (2019) Cold agglutinin disease: current challenges and future prospects. Journal of Blood Medicine 10, pages 93-103.
Read now
Maria Celeste Fatone, Fabio Pavone, Gianfranco Lauletta & Sabino Russi. (2018) Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia. Autoimmunity 51:4, pages 166-174.
Read now
Wilma Barcellini. (2015) Current treatment strategies in autoimmune hemolytic disorders. Expert Review of Hematology 8:5, pages 681-691.
Read now
Marc Michel. (2011) Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Review of Hematology 4:6, pages 607-618.
Read now
Pascal Sève, Pierre Philippe, Jean-François Dufour, Christiane Broussolle & Marc Michel. (2008) Autoimmune hemolytic anemia: classification and therapeutic approaches. Expert Review of Hematology 1:2, pages 189-204.
Read now
Enno Schmidt & Matthias Goebeler. (2008) CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab. Expert Review of Dermatology 3:3, pages 259-278.
Read now
Sigbjørn Berentsen, Klaus Beiske & Geir E. Tjønnfjord. (2007) Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy. Hematology 12:5, pages 361-370.
Read now
Kai-Ni Shen, Dan-Qing Zhao, Yue-Ying Mao, Hua-Cong Cai, Jian Li & Xin-Xin Cao. Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone. Leukemia & Lymphoma 0:0, pages 1-3.
Read now

Articles from other publishers (116)

Donald C. Moore & Justin R. Arnall. (2022) Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease–Associated Hemolysis. Annals of Pharmacotherapy 57:8, pages 970-977.
Crossref
P. I. Vasilchenkova, I. V. Galtseva & E. A. Lukina. (2023) Autoimmune hemolytic anemia: the current state of the issue. Oncohematology 18:2, pages 60-67.
Crossref
Georg Gelbenegger, Ulrich Jäger, Michael Fillitz, Christian Schörgenhofer, Christian Sillaber & Bernd Jilma. (2023) Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease. Blood Advances 7:10, pages 1987-1990.
Crossref
Sigbjørn Berentsen, Bruno Fattizzo & Wilma Barcellini. (2023) The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?. Frontiers in Immunology 14.
Crossref
Ilene Weitz. (2023) Sutimlimab for the Treatment of Cold Agglutinin Disease. Oncology & Haematology 19:1, pages 35.
Crossref
Warren Balaja, Paul Schmidt & Ardy Fenando. (2023) Cold agglutinin disease: A case report with atypical clinical findings. SAGE Open Medical Case Reports 11.
Crossref
Sigbjørn Berentsen. (2023) Sutimlimab for the Treatment of Cold Agglutinin Disease. HemaSphere 7:5, pages e879.
Crossref
Catherine M. Broome, Naushin Hooda, Jun Su, Xiaohui Jiang, Gina Nicholson, Cara L. Frankenfeld, Melitza Iglesias-Rodriguez, Jon Fryzek & Parija Patel. (2022) Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States. PLOS ONE 17:12, pages e0276617.
Crossref
Jenny McDade Despotovic & Taylor Olmsted Kim. (2022) Cold AIHA and the best treatment strategies. Hematology 2022:1, pages 90-95.
Crossref
Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa & Bernd Jilma. (2022) Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?. Immunotherapy 14:15, pages 1191-1204.
Crossref
Sigbjørn Berentsen & Geir E. Tjønnfjord. (2022) Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?. Transfusion Medicine Reviews 36:4, pages 181-187.
Crossref
Alexander Röth, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, David J. Kuter, Jun Su, Xiaoyu Jiang, William Hobbs, Jaime Morales Arias, Frank Shafer & Ilene C. Weitz. (2022) Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study. Annals of Hematology 101:10, pages 2169-2177.
Crossref
Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka & Josephine M. I. Vos. (2022) Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy. Hemato 3:4, pages 574-594.
Crossref
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M. I. Vos, Michael Storek, Nancy Wong, Parija Patel, Xiaoyu Jiang, Deepthi S. Vagge, Marek Wardęcki, Frank Shafer, Michelle Lee & Catherine M. Broome. (2022) Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood 140:9, pages 980-991.
Crossref
Zhengrui Xiao & Irina Murakhovskaya. (2022) Development of New Drugs for Autoimmune Hemolytic Anemia. Pharmaceutics 14:5, pages 1035.
Crossref
Douglas Blackall & Lily Dolatshahi. (2022) Autoimmune Hemolytic Anemia in Children: Laboratory Investigation, Disease Associations, and Treatment Strategies. Journal of Pediatric Hematology/Oncology 44:3, pages 71-78.
Crossref
Steven R. Hwang, Antoine N. Saliba & Alexandra P. Wolanskyj-Spinner. (2022) Immunotherapy-associated Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 36:2, pages 365-380.
Crossref
Edit Porpaczy & Ulrich Jäger. (2022) How I manage autoimmune cytopenias in patients with lymphoid cancer. Blood 139:10, pages 1479-1488.
Crossref
Christopher J. Patriquin & Katerina Pavenski. (2021) O, wind, if winter comes … will symptoms be far behind?. Transfusion 62:1, pages 2-10.
Crossref
Sigbjørn Berentsen & Wilma Barcellini. (2021) Autoimmune Hemolytic Anemias. New England Journal of Medicine 385:15, pages 1407-1419.
Crossref
Nil Albiol & Carol Moreno. (2021) Autoimmune Cytopenia in CLL. The Cancer Journal 27:4, pages 286-296.
Crossref
Sigbjørn Berentsen. (2021) How I treat cold agglutinin disease. Blood 137:10, pages 1295-1303.
Crossref
Sylwia Sulimiera Michalak. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 553 563 .
Irina Murakhovskaya. (2020) Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia. Journal of Clinical Medicine 9:12, pages 4034.
Crossref
Shih-Hsuan Chao, Yuh-Lih Chang, Jiin-Cherng Yen, Hsien-Tzung Liao, Tsai-Hung Wu, Chia-Li Yu, Chang-Youh Tsai & Yueh-Ching Chou. (2020) Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis. Experimental Hematology & Oncology 9:1.
Crossref
Sylwia Sulimiera Michalak, Anna Olewicz-Gawlik, Joanna Rupa-Matysek, Edyta Wolny-Rokicka, Elżbieta Nowakowska & Lidia Gil. (2020) Autoimmune hemolytic anemia: current knowledge and perspectives. Immunity & Ageing 17:1.
Crossref
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta & Bruno Fattizzo. (2020) New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy. Journal of Clinical Medicine 9:12, pages 3859.
Crossref
Ming-nan Jia, Yu Qiu, Yan-yan Wu, Hao Cai, Dao-bin Zhou, Xin-xin Cao & Jian Li. (2020) Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients. Scientific Reports 10:1.
Crossref
Sigbjørn Berentsen, Wilma BarcelliniShirley D’SaUlla RandenTor Henrik Anderson TvedtBruno Fattizzo, Einar HaukåsMegan KellRobert BrudevoldAnders E. A. DahmJakob DalgaardHege FrøenRandi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth-Hansen, Agnieszka MałeckaMarkku OksmanJürgen RolkeMallika SekharJon Hjalmar Sørbø, Eirik Tjønnfjord, Galina TsykunovaGeir E. Tjønnfjord. (2020) Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 136:4, pages 480-488.
Crossref
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, Morie A. Gertz, Anita Hill, Quentin A. Hill, Bernd Jilma, David J. Kuter, Marc Michel, Marco Montillo, Alexander Röth, Sacha S. Zeerleder & Sigbjørn Berentsen. (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Reviews 41, pages 100648.
Crossref
Sigbjørn Berentsen. (2020) New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Frontiers in Immunology 11.
Crossref
Carlos Jose Atencia & Catalina Quintero. (2020) Primera serie de casos reportada en Colombia de la enfermedad por aglutininas frías primaria y secundaria.. Iatreia 33:2, pages 123-132.
Crossref
Ruth Perez. 2020. Rodak's Hematology. Rodak's Hematology 378 393 .
Quentin A. Hill, Anita Hill & Sigbjørn Berentsen. (2019) Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Advances 3:12, pages 1897-1906.
Crossref
Øystein Sefland, Ulla Randen & Sigbjørn Berentsen. (2019) Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?. Case Reports in Hematology 2019, pages 1-6.
Crossref
Ulrich JägerShirley D’SaChristian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Christian SillaberPetra Jilma-StohlawetzMichael FillitzThomas SchenkGary Patou, Sandip Panicker, Graham C. Parry, James C. Gilbert & Bernd Jilma. (2019) Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. Blood 133:9, pages 893-901.
Crossref
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, Tor Henrik Anderson Tvedt & Marc Michel. (2019) Novel insights into the treatment of complement-mediated hemolytic anemias. Therapeutic Advances in Hematology 10, pages 204062071987332.
Crossref
Sylwia Sulimiera Michalak. 2019. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 1 10 .
T. Klejtman, B. Garel, P. Senet, L. Tribout, C. Bachmeyer, A. Barbaud & J.-B. Monfort. (2018) Nécroses digitales révélant une maladie des agglutinines froides : traitement par rituximab. Annales de Dermatologie et de Vénéréologie 145:12, pages 761-764.
Crossref
Giuseppe RossiDoriana GramegnaFrancesca PaoloniBruno FattizzoFrancesca BindaMariella D’AddaMirko FarinaElisa LucchiniFrancesca Romana MauroFlavia Salvi, Monia Marchetti, Paola FaziFrancesco ZajaWilma Barcellini. (2018) Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. Blood 132:5, pages 547-550.
Crossref
Sigbjørn Berentsen. (2018) Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease. Seminars in Hematology 55:3, pages 141-149.
Crossref
Sigbjørn Berentsen. (2018) How I manage patients with cold agglutinin disease. British Journal of Haematology 181:3, pages 320-330.
Crossref
Sigbjørn BerentsenUlla RandenMarkku OksmanHenrik BirgensTor Henrik Anderson TvedtJakob DalgaardEivind GaltelandEinar HaukåsRobert BrudevoldJon Hjalmar SørbøInger Anne NæssAgnieszka Malecka & Geir E. Tjønnfjord. (2017) Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial. Blood 130:4, pages 537-541.
Crossref
Ronald S. Go, Jeffrey L. Winters & Neil E. Kay. (2017) How I treat autoimmune hemolytic anemia. Blood 129:22, pages 2971-2979.
Crossref
Megan MullinsXiaohui JiangLauren C. BylsmaJon P. FryzekHeidi ReichertEvan C. Chen, Shivaani Kummar & Adam Rosenthal. (2017) Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Advances 1:13, pages 839-848.
Crossref
Quentin A. Hill, Robert Stamps, Edwin Massey, John D. Grainger, Drew Provan & Anita Hill. (2017) The diagnosis and management of primary autoimmune haemolytic anaemia. British Journal of Haematology 176:3, pages 395-411.
Crossref
Kana Oiwa, Shinji Kishi, Yumie Ebita, Yasufumi Matsuda, Katsunori Tai, Yoshimasa Urasaki, Tadakazu Okoshi, Yoshiaki Imamura & Takahiro Yamauchi. (2017) B-CELL LYMPHOMA COMPLICATED BY COLD AGGLUTININ DISEASE EFFECTIVELY MANAGED WITH R-CHOP. Japanese Journal of Transfusion and Cell Therapy 63:4, pages 607-613.
Crossref
Marvin J. Stone & Sigbjorn Berentsen. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 171 183 .
Sigbjørn Berentsen. (2016) Cold agglutinin disease. Hematology 2016:1, pages 226-231.
Crossref
L Rotenstein, A Nathan, I Ghobrial, J Antin & A Parnes. (2016) Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. Bone Marrow Transplantation 51:11, pages 1504-1506.
Crossref
Kamel Laribi, Delphine Bolle, Habib Ghnaya, Andrea Sandu, Anne Besançon, Nathalie Denizon, Catherine Truong, Fabienne Pineau-Vincent & Alix Baugier de Materre. (2016) Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA. Annals of Hematology 95:5, pages 765-769.
Crossref
Shun-ichi Shimano, Yoichi Hoshino, Satoru Ohmura, Moriya Machida, Teizo Taya, Isao Yamada, Takeshi Arai, Nozomi Togo, Koichi Suto, Shigeo Kawai, Toshiro Ikeya, Yasushi Togo, Hideaki Itoh & Masaru Kojima. (2016) Two Cases of Lymph Node Infarction:. The KITAKANTO Medical Journal The Kitakanto Medical Journal 66:3, pages 217-222.
Crossref
Narges Seyfizadeh, Nayer Seyfizadeh, Justin Hasenkamp & Sara Huerta-Yepez. (2016) A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections. Critical Reviews in Oncology/Hematology 97, pages 275-290.
Crossref
Kamille A. West & Susan F. Leitman. 2016. Nonmalignant Hematology. Nonmalignant Hematology 707 718 .
Mark Boonyasampant, Ilene C. Weitz, Brian Kay, Chaiyaporn Boonchalermvichian, Howard A. Liebman & Ira A. Shulman. (2015) Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 55:10, pages 2398-2403.
Crossref
Wilma Barcellini. (2015) Immune Hemolysis: Diagnosis and Treatment Recommendations. Seminars in Hematology 52:4, pages 304-312.
Crossref
Sigbjørn Berentsen, Ulla Randen & Geir E. Tjønnfjord. (2015) Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America 29:3, pages 455-471.
Crossref
Chaturaka Rodrigo, Senaka Rajapakse & Lallindra Gooneratne. (2015) Rituximab in the treatment of autoimmune haemolytic anaemia. British Journal of Clinical Pharmacology 79:5, pages 709-719.
Crossref
Quitterie Reynaud, Isabelle Durieu, Marine Dutertre, Stanislas Ledochowski, Stéphane Durupt, Anne-Sophie Michallet, Denis Vital-Durand & Jean-Christophe Lega. (2015) Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. Autoimmunity Reviews 14:4, pages 304-313.
Crossref
Sigbjørn Berentsen. (2015) Role of Complement in Autoimmune Hemolytic Anemia. Transfusion Medicine and Hemotherapy 42:5, pages 303-310.
Crossref
Sigbjørn Berentsen & Tatjana Sundic. (2015) Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy. BioMed Research International 2015, pages 1-11.
Crossref
Wilma BarcelliniBruno FattizzoAnna ZaninoniTommaso RadiceIlaria NicheleEros Di BonaMonia LunghiCristina TassinariFiorella AlfinitoAntonella FerrariAnna Paola LeporacePasquale NiscolaMonica CarpenedoCarla BoschettiNicoletta Revelli, Maria Antonietta Villa, Dario Consonni, Laura ScaramucciPaolo De FabritiisGiuseppe TagarielloGianluca GaidanoFrancesco RodeghieroAgostino Cortelezzi & Alberto Zanella. (2014) Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood 124:19, pages 2930-2936.
Crossref
Ju Shi, Eileen L. Rose, Andrew Singh, Sami Hussain, Nancy E. Stagliano, Graham C. Parry & Sandip Panicker. (2014) TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins. Blood 123:26, pages 4015-4022.
Crossref
Cathrin Arthold, Cathrin Skrabs, Gerlinde Mitterbauer-Hohendanner, Renate Thalhammer, Ingrid Simonitsch-Klupp, Simon Panzer, Peter Valent, Klaus Lechner, Ulrich Jäger & Christian Sillaber. (2014) Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findingsDie autoimmunhämolytische Anämie vom Kältetyp: eine retrospektive Analyse von 20 Patienten unter Berücksichtigung klinischer, hämatologischer und molekularer Aspekte. Wiener klinische Wochenschrift 126:11-12, pages 376-382.
Crossref
Roger G. Owen, Guy Pratt, Rebecca L. Auer, Rita Flatley, Charalampia Kyriakou, Michael P. Lunn, Francis Matthey, Helen McCarthy, Feargal P. McNicholl, Saad M. Rassam, Simon D. Wagner, Matthew Streetly & Shirley D'Sa. (2014) Guidelines on the diagnosis and management of Waldenström macroglobulinaemia. British Journal of Haematology 165:3, pages 316-333.
Crossref
Neha Gupta & Eunice S. Wang. (2013) Long-term response of refractory primary cold agglutinin disease to eculizumab therapy. Annals of Hematology 93:2, pages 343-344.
Crossref
. 2014. Mollison's Blood Transfusion in Clinical Medicine. Mollison's Blood Transfusion in Clinical Medicine 259 302 .
Bassem N. Matta, Rabih Nayfe, Ali T. Taher & Imad Uthman. 2014. Drugs Targeting B-Cells in Autoimmune Diseases. Drugs Targeting B-Cells in Autoimmune Diseases 193 217 .
Wilma Barcellini, Francesco Zaja, Anna Zaninoni, Francesca Guia Imperiali, Eros Di Bona, Bruno Fattizzo, Dario Consonni, Agostino Cortelezzi & Alberto Zanella. (2013) Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia. European Journal of Haematology 91:6, pages 546-551.
Crossref
Henrik Birgens, Henrik Frederiksen, Hans C. Hasselbalch, Inge H. Rasmussen, Ove J. Nielsen, Lars Kjeldsen, Herdis Larsen, Torben Mourits-Andersen, Torben Plesner, Dorthe Rønnov-Jessen, Hanne Vestergaard, Tobias W. Klausen & Claudia Schöllkopf. (2013) A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia . British Journal of Haematology 163:3, pages 393-399.
Crossref
José Carlos Jaime-Pérez, Marisol Rodríguez-Martínez, Andrés Gómez-de-León, Luz Tarín-Arzaga & David Gómez-Almaguer. (2013) Current Approaches for the Treatment of Autoimmune Hemolytic Anemia. Archivum Immunologiae et Therapiae Experimentalis 61:5, pages 385-395.
Crossref
Paul L. Swiecicki, Livia T. Hegerova & Morie A. Gertz. (2013) Cold agglutinin disease. Blood 122:7, pages 1114-1121.
Crossref
Hiroaki Tanaka, Shinichiro Hashimoto, Yasumasa Sugita, Shio Sakai, Yusuke Takeda, Daijiro Abe, Toshiyuki Takagi & Chiaki Nakaseko. (2012) Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy. International Journal of Hematology 96:4, pages 501-505.
Crossref
Daan Dierickx, Emilie Beke, Timothy Devos & André Delannoy. (2012) The Use of Monoclonal Antibodies in Immune-Mediated Hematologic Disorders. Medical Clinics of North America 96:3, pages 583-619.
Crossref
Sigbjørn Berentsen & Geir E. Tjønnfjord. (2012) Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Reviews 26:3, pages 107-115.
Crossref
Wilma BarcelliniFrancesco ZajaAnna ZaninoniFrancesca Guia ImperialiMarta Lisa BattistaEros Di BonaBruno FattizzoDario Consonni, Agostino Cortelezzi, Renato FaninAlberto Zanella. (2012) Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood 119:16, pages 3691-3697.
Crossref
Marjana Glaser, Andrej Glaser & Marjan Skalicky. (2011) Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemiaLangfristige Remission durch Rituximab bei einer Patientin mit primär chronischer autoimmunhämolytischen Anämie durch Kälteagglutinine. Wiener klinische Wochenschrift 123:21-22, pages 680-683.
Crossref
Wilma Barcellini & Alberto Zanella. (2011) Rituximab therapy for autoimmune haematological diseases. European Journal of Internal Medicine 22:3, pages 220-229.
Crossref
Sigbjørn Berentsen. (2011) How I manage cold agglutinin disease. British Journal of Haematology 153:3, pages 309-317.
Crossref
Charles H Packman. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Daan Dierickx, André Delannoy, Khalid Saja, Gregor Verhoef & Drew Provan. (2011) Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. American Journal of Hematology 86:3, pages 278-291.
Crossref
Claudio Fozza & Maurizio Longinotti. (2011) Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas. Advances in Hematology 2011, pages 1-4.
Crossref
Emmanuel Andrès, Helen Fothergill & Mustapha Mecili. 2011. Autoimmune Diseases. Autoimmune Diseases 259 273 .
Francisco Javier Peñalver, Alberto Alvarez-Larrán, Jose Luis Díez-Martin, Laura Gallur, Isidro Jarque, Dolores Caballero, Joaquín Díaz-Mediavilla, Rosalía Bustelos, María Jesús Fernández-Aceñero & José Rafael Cabrera. (2010) Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Annals of Hematology 89:11, pages 1073-1080.
Crossref
Sigbjørn BerentsenUlla RandenAnne Marita VåganHenrik Hjorth-HansenAnders VikJakob DalgaardEva-Marie Jacobsen, Aud S. Thoresen, Klaus BeiskeGeir E. Tjønnfjord. (2010) High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood 116:17, pages 3180-3184.
Crossref
Klaus Lechner & Ulrich Jäger. (2010) How I treat autoimmune hemolytic anemias in adults. Blood 116:11, pages 1831-1838.
Crossref
P. Lehmann, W. Hartung, B. Ehrenstein, J. Schölmerich & M. Fleck. (2010) Rheumatoide Arthritis und AutoimmunhämolyseRheumatoid arthritis and autoimmune hemolysis. Zeitschrift für Rheumatologie 69:6, pages 557-560.
Crossref
A. Khalafallah, L. J. Vos, M. Beamish & K. Rooney. (2010) Successful rituximab therapy in the treatment of refractory cold haemagglutinin disease with long‐term disease control. Internal Medicine Journal 40:5, pages 387-389.
Crossref
Evan P. Kransdorf & Murat O. Arcasoy. (2010) Unraveling a Sticky Paradox. The American Journal of Medicine 123:5, pages 417-419.
Crossref
Roberto Stasi. (2010) Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells. Seminars in Hematology 47:2, pages 170-179.
Crossref
Nandakumar Srinivasan, Alok Oswal, Sindhu Garg, Albina Gosmonova, Julie Nahar & Roopesh Nahar. (2010) Cold Agglutinin Induced Hemolysis in a Newly Diagnosed Systemic Lupus Erythematosus. The American Journal of the Medical Sciences 339:3, pages 270-273.
Crossref
Norimichi Hattori, Noriko Ishii, Hirotsugu Ariizumi, Daisuke Adachi, Isao Matsuda, Tsuyoshi Nakamaki & Shigeru Tomoyasu. (2009) Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström’s macroglobulinemia. Annals of Hematology 89:1, pages 103-104.
Crossref
D. Dierickx, G. Verhoef, A. Van Hoof, P. Mineur, A. Roest, A. Triffet, A. Kentos, P. Pierre, D. Boulet, G. Bries, P-Q Lê, A. Janssens & A. Delannoy. (2009) Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Journal of Internal Medicine 266:5, pages 484-491.
Crossref
Thomas Dörner, Andreas Radbruch & Gerd R. Burmester. (2009) B-cell-directed therapies for autoimmune disease. Nature Reviews Rheumatology 5:8, pages 433-441.
Crossref
Sigbjørn Berentsen. (2009) Cold Agglutinin–Mediated Autoimmune Hemolytic Anemia in Waldenström's Macroglobulinemia. Clinical Lymphoma and Myeloma 9:1, pages 110-112.
Crossref
Roy M. Fleischmann. (2009) Safety of Biologic Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases: Focus on Rituximab. Seminars in Arthritis and Rheumatism 38:4, pages 265-280.
Crossref
Sigbjørn Berentsen, Tatjana Sundic, Tor Hervig & Geir Tjønnfjord. (2009) Autoimmun hemolytisk anemi. Tidsskrift for Den norske legeforening 129:21, pages 2226-2231.
Crossref
Hakan M. Gürcan, Derin B. Keskin, Joel N.H. Stern, Matthew A. Nitzberg, Haris Shekhani & A. Razzaque Ahmed. (2009) A review of the current use of rituximab in autoimmune diseases. International Immunopharmacology 9:1, pages 10-25.
Crossref
M. Michel. (2009) Anémies hémolytiques auto-immunes. EMC - Hématologie 4:2, pages 1-10.
Crossref
Daan Dierickx, Anja De Rycke, Steven Vanderschueren & André Delannoy. (2008) New treatment options for immune-mediated hematological disorders. European Journal of Internal Medicine 19:8, pages 579-586.
Crossref
P. Fiorina, A. Vergani, S. Dada, M. Jurewicz, M. Wong, K. Law, E. Wu, Z. Tian, R. Abdi, I. Guleria, S. Rodig, K. Dunussi-Joannopoulos, J. Bluestone & M. H. Sayegh. (2008) Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes. Diabetes 57:11, pages 3013-3024.
Crossref
U. PANWAR, C. MATHEWS & J. O. CULLIS. (2008) Cost-effectiveness of rituximab in refractory cold agglutinin disease. International Journal of Laboratory Hematology 30:4, pages 331-333.
Crossref
N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi & A. Quattrini. (2008) LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE. Neurology 70:19, pages 1715-1716.
Crossref
Bernadette Garvey. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology 141:2, pages 149-169.
Crossref
Peter Valent & Klaus Lechner. (2008) Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical reviewDiagnose und Therapie von autoimmunhämolytischen Anämien im Erwachsenen: Eine klinische Übersicht. Wiener klinische Wochenschrift 120:5-6, pages 136-151.
Crossref
Laurent Sailler. (2007) Rituximab Off Label Use for Difficult-To-Treat Auto-Immune Diseases: Reappraisal of Benefits and Risks. Clinical Reviews in Allergy & Immunology 34:1, pages 103-110.
Crossref
Lawrence D. Petz. (2008) Cold antibody autoimmune hemolytic anemias. Blood Reviews 22:1, pages 1-15.
Crossref
D. G. Arkfeld. (2007) The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatology International 28:3, pages 205-215.
Crossref
Pierre Philippe. (2007) Diagnostic et prise en charge de l'anémie hémolytique auto-immune. La Presse Médicale 36:12, pages 1959-1969.
Crossref
Morie A. Gertz. (2007) Management of cold haemolytic syndrome. British Journal of Haematology 138:4, pages 422-429.
Crossref
Giovanni D?Arena, Catello Califano, Mario Annunziata, Alfredo Tartarone, Silvana Capalbo, Oreste Villani, Giovanni Amendola, Giuseppe Pietrantuono, Felicetto Ferrara, Antonio Pinto, Pellegrino Musto, Alfonso Maria D?Arco & Nicola Cascavilla. (2007) Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. European Journal of Haematology 79:1, pages 53-58.
Crossref
Thomas E. Witzig, David J. Inwards, Thomas M. Habermann, Ahmet Dogan, Paul J. Kurtin, John B. GrossJrJr, Anuradha Ananthamurthy, Kay M. Ristow & James A. Garrity. (2007) Treatment of Benign Orbital Pseudolymphomas With the Monoclonal Anti-CD20 Antibody Rituximab. Mayo Clinic Proceedings 82:6, pages 692-699.
Crossref
Giampaolo MerliniMarvin J. Stone. (2006) Dangerous small B-cell clones. Blood 108:8, pages 2520-2530.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:2, pages 89-96.
Crossref
Gregory J. BrunnSoheyla SaadiJeffrey L. Platt. (2006) Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1α. Circulation Research 98:6, pages 793-800.
Crossref
Morie A. Gertz. (2006) Cold Hemolytic Syndrome. Hematology 2006:1, pages 19-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.